Tompkins Financial’s AbbVie ABBV Stock Holding History

Tompkins Financial’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.9M	Buy	35,368 +220	+0.6%	+$47.3K	0.62%	39
2026 Q1	$7.64M	Sell	35,148 -105	-0.3%	-$23.3K	0.61%	44
2025 Q4	$8.05M	Sell	35,253 -4	-0%	-$911	0.63%	46
2025 Q3	$8.16M	Hold	35,257	–	–	0.68%	41
2025 Q2	$6.54M	Buy	35,257 +37	+0.1%	+$6.88K	0.6%	45
2025 Q1	$7.38M	Sell	35,220 -507	-1%	-$98.6K	0.71%	43
2024 Q4	$6.35M	Buy	35,727 +1,956	+6%	+$360K	0.59%	44
2024 Q3	$6.67M	Sell	33,771 -2,854	-8%	-$533K	0.64%	44
2024 Q2	$6.28M	Sell	36,625 -79	-0.2%	-$13.1K	0.66%	44
2024 Q1	$6.68M	Sell	36,704 -455	-1%	-$78.4K	0.76%	42
2023 Q4	$5.76M	Buy	37,159 +3,808	+11%	+$555K	0.7%	45
2023 Q3	$4.97M	Sell	33,351 -39	-0.1%	-$5.72K	0.78%	43
2023 Q2	$4.5M	Sell	33,390 -979	-3%	-$144K	0.7%	47
2023 Q1	$5.48M	Sell	34,369 -97	-0.3%	-$14.8K	0.89%	37
2022 Q4	$5.57M	Sell	34,466 -184	-0.5%	-$28.2K	0.88%	38
2022 Q3	$4.65M	Buy	34,650 +309	+0.9%	+$44.3K	0.78%	41
2022 Q2	$5.26M	Sell	34,341 -1,224	-3%	-$187K	0.85%	39
2022 Q1	$5.77M	Buy	35,565 +26,832	+307%	+$3.9M	0.81%	40
2021 Q4	$1.18M	Sell	8,733 -334	-4%	-$39.5K	0.21%	71
2021 Q3	$978K	Buy	+9,067	New	+$1.04M	0.18%	74
2021 Q1	$1.03M	Hold	9,541	–	–	0.17%	74
2020 Q4	$1.02M	Sell	9,541 -315	-3%	-$30.3K	0.18%	72
2020 Q3	$863K	Sell	9,856 -582	-6%	-$54.8K	0.17%	78
2020 Q2	$1.02M	Buy	10,438 +414	+4%	+$36.5K	0.22%	73
2020 Q1	$764K	Sell	10,024 -1,175	-10%	-$100K	0.18%	78
2019 Q4	$992K	Sell	11,199 -1,000	-8%	-$83K	0.18%	78
2019 Q3	$924K	Sell	12,199 -2,459	-17%	-$169K	0.19%	78
2019 Q2	$1.07M	Sell	14,658 -1,696	-10%	-$133K	0.21%	74
2019 Q1	$1.32M	Buy	16,354 +1,057	+7%	+$86.5K	0.25%	71
2018 Q4	$1.41M	Sell	15,297 -652	-4%	-$57.3K	0.31%	67
2018 Q3	$1.51M	Sell	15,949 -407	-2%	-$38.6K	0.31%	67
2018 Q2	$1.51M	Buy	16,356 +963	+6%	+$94K	0.33%	66
2018 Q1	$1.46M	Buy	15,393 +4,550	+42%	+$500K	0.33%	67
2017 Q4	$1.05M	Sell	10,843 -20,540	-65%	-$1.94M	0.24%	75
2017 Q3	$2.79M	Buy	31,383 +20,986	+202%	+$1.6M	0.66%	40
2017 Q2	$754K	Sell	10,397 -41	-0.4%	-$2.76K	0.19%	89
2017 Q1	$681K	Sell	10,438 -229	-2%	-$14.4K	0.17%	88
2016 Q4	$668K	Sell	10,667 -1,000	-9%	-$61K	0.18%	86
2016 Q3	$735K	Sell	11,667 -2,240	-16%	-$145K	0.21%	78
2016 Q2	$861K	Buy	13,907 +65	+0.5%	+$3.96K	0.25%	73
2016 Q1	$791K	Sell	13,842 -2,374	-15%	-$132K	0.25%	81
2015 Q4	$960K	Sell	16,216 -25,684	-61%	-$1.48M	0.31%	74
2015 Q3	$2.28M	Sell	41,900 -174	-0.4%	-$11.3K	0.74%	33
2015 Q2	$2.83M	Buy	42,074 +771	+2%	+$50.3K	0.77%	28
2015 Q1	$2.42M	Buy	41,303 +4,983	+14%	+$301K	0.61%	35
2014 Q4	$2.38M	Buy	36,320 +8,210	+29%	+$518K	0.59%	38
2014 Q3	$1.62M	Buy	28,110 +1,474	+6%	+$81.8K	0.43%	47
2014 Q2	$1.5M	Buy	26,636 +132	+0.5%	+$6.92K	0.37%	52
2014 Q1	$1.36M	Buy	26,504 +656	+3%	+$33.2K	0.34%	58
2013 Q4	$1.36M	Buy	25,848 +2,937	+13%	+$144K	0.35%	58
2013 Q3	$1.02M	Buy	22,911 +1,211	+6%	+$53.7K	0.29%	72
2013 Q2	$897K	Buy	+21,700	New	+$949K	0.27%	73

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Tompkins Financial's ABBV Position: Q2 2026 in Review

Tompkins Financial increased its AbbVie (ABBV) stake by 0.63% in Q2 2026, buying an estimated $47.3K and bringing the position to 35,368 shares worth $8.9M. The position accounts for 0.62% of the portfolio, ranked #39.

Tompkins Financial first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Tompkins Financial held 35,368 shares of AbbVie worth $8.9M as of Q2 2026.
Tompkins Financial bought 220 AbbVie shares in Q2 2026, an estimated $47.3K.
AbbVie made up 0.62% of Tompkins Financial's portfolio in Q2 2026, its #39 holding.
Tompkins Financial first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Tompkins Financial's 13F filing for Q2 2026, filed 15 Jul 2026.